VALIDATED EXECUTIVE ENGAGEMENTS
OUTREACH
10862
Number of executives repeatedly engaged by snail & email outreach
INTERACTIONS
1303
Interactions with Platform & by Email
PARTICIPANTS
326
Unique # Participated
VALIDATIONS
147
Responses Validated*
* Login to view program details and full enterprise executive list.
DATE
SEP 2020
TABLES
138
PAGES
248
EDITION
18
PRICE
USD $5450
It Pays to Understand the Dynamics of Competition in Your Business Ecosystem.
Who Are Your Competitors in the Companion Diagnostics Market?
Amid the COVID-19 crisis, the global market for Companion Diagnostics estimated at US$3.4 Billion in the year 2020, is projected to reach a revised size of US$9.2 Billion by 2027, growing at aCAGR of 15.1% over the period 2020-2027. Assay kits & Reagents, one of the segments analyzed in the report, is projected to record 14.3% CAGR and reach US$6 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Software & Services segment is readjusted to a revised 16.8% CAGR for the next 7-year period.
The Companion Diagnostics market in the U.S. is estimated at US$1 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.6 Billion by the year 2027 trailing a CAGR of 14.6% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 13.5% and 13% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 11.1% CAGR.We bring years of research experience to this 18th edition of our report. The 248-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.
Abbott Molecular; Agilent Technologies, Inc.; bioMérieux SA; Cepheid; Danaher Corporation; F. Hoffmann-La Roche Ltd.; Foundation Medicine Inc.; Laboratory Corporation of America® Holdings; Leica Biosystems Nussloch GmbH; Merck & Co. Inc.; Myriad Genetics Inc.; NeoGenomics Laboratories, Inc.; QIAGEN N.V.; Quest Diagnostics Inc.; Thermo Fischer Scientific Inc.
» Product & Service (Assay kits & Reagents, Software & Services) » Technology (Polymerase Chain Reaction (PCR), Immunohistochemistry (IHC), In Situ Hybridization (ISH), Next-Generation Sequencing (NGS), Other Technologies) » Indication (Oncology, Neurology, Other Indications) » End-Use (Pharmaceutical & Biopharmaceutical Companies, Reference Laboratories, CROs, Other End-Uses)
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World
INSIDER ACCESS PRIVILEGES
Users of our portal have insider access to our data stacks based on project relevance and engagement status. Tiered access is offered to data stacks, managed based on user status - Opt-in, Active Panelist, Inactive Panelist, Active Client or Inactive Client.
KEY DIFFERENTIATORS
We are firmly committed to build upon perspectives from global executive insights. These engagements enrich our projects. Our primary research programs are fully validated and accessible by clients. (Its a common industry-wide* practice that no validated primary research is done! For the most part, remote resident analysts curate and write reports drawing on search engine research and data modeling.
* A review of 262 off-the-shelf market report publishers worldwide.
WHAT SETS US APART
Client companies can access multiple features on our MarketGlassâ„¢ platform.
Clients have full-stack insider access to our ongoing primary research program. We have a very successful incentive driven primary research program that benefits participating executives regardless of their purchase decision. Our platform presents a unique opportunity to collaborate with peers and review competitors’ inputs and response clusters.
Detailed engagement stats are presented for every company and executive contacted. This is made available for our client reviews. (no other publisher offers this!)
A full-stack access to clients of all primary and secondary source content. This can often run into thousands of pages.
Where relevent and possible we present competitive brands.
Peer-to-peer online interactive collaborations. Allows for team curated bespoke analytics.
Customers can update and build bespoke versions of our analytics. Bespoke updates are fulfilled within a two-day turnaround.
Discretely bounce off queries to participant pool of executives. Our embedded AI selectively pings participants geographically and by domain acumen.
We pride in our commitment to provide support to our clients. We go beyond the scope of the study to get you timely answers.
Unlike the industry’s published PDF’s that are frozen in time from date of release, our research programs are ongoing and dynamic. Our reports are updated whenever there’s a major event impacting the marketplace. Your license offers seamless updates for one year.
All updates are offered for one year from date of your purchase without charge. Clients can opt for annual auto renewal and stay current without interruption.
05
| I. INTRODUCTION, METHODOLOGY & REPORT SCOPE |
| II. EXECUTIVE SUMMARY |
| 1. MARKET OVERVIEW |
| Impact of Covid-19 and a Looming Global Recession |
| Companion Diagnostics: An Introductory Prelude |
| Quashing the One-Size-Fits-All Approach, CDx Wield Great Promise for Streamlined Drug Discovery & Development |
| Broader Scope and Applications Rev Up Growth Opportunities |
| Healthy Growth Projected over the Next Few Years |
| Developed Regions: Key Revenue Contributors |
| Market Witnesses Fast Paced Growth in Developing Regions |
| Northbound Trajectory in R&D Spending Creates Conducive Environment |
| Prevailing Economic Scenario Favors Funding Pattern |
| Global Competitor Market Shares |
| Companion Diagnostics Competitor Market Share Scenario Worldwide (in %): 2018 & 2029 |
| 2. FOCUS ON SELECT PLAYERS |
| 3. MARKET TRENDS & DRIVERS |
| Growing Significance of Personalized Medicine Remains a Major Market Driver |
| Emphasis on Improving Targeted Therapies with CDx Tests Steers Momentum |
| Herceptin Lays the Road for Companion Diagnostics |
| Oncology - Dominant Therapy Area for CDx |
| Rising Incidence of Cancer Propels the Need for CDx Tests |
| Technology Advancements to Widen CDx Use Case |
| PCR: Dominant Technology Type for CDx Testing |
| Next-Generation Sequencing (NGS) Gains Widespread Traction in CDx Testing |
| Significant Role of Biomarkers in Companion Diagnostics |
| Critical Healthcare Needs of Aging Population Underpin CDx Sales |
| Regulatory Scenario Favors CDx Market |
| Resolving Prevailing Challenges: Critical for Future Growth of CDx Market |
| 4. GLOBAL MARKET PERSPECTIVE |
| Companion Diagnostics Global Market Estimates and Forecasts in US$ Million by Region/Country: 2020-2027 |
| Companion Diagnostics Market Share Shift across Key Geographies Worldwide: 2020 VS 2027 |
| Assay kits & Reagents (Product & Service) World Market by Region/Country in US$ Million: 2020 to 2027 |
| Assay kits & Reagents (Product & Service) Market Share Breakdown of Worldwide Sales by Region/Country: 2020 VS 2027 |
| Software & Services (Product & Service) Potential Growth Markets Worldwide in US$ Million: 2020 to 2027 |
| Software & Services (Product & Service) Market Sales Breakdown by Region/Country in Percentage: 2020 VS 2027 |
| Polymerase Chain Reaction (PCR) (Technology) Geographic Market Spread Worldwide in US$ Million: 2020 to 2027 |
| Polymerase Chain Reaction (PCR) (Technology) Market Share Distribution in Percentage by Region/Country: 2020 VS 2027 |
| Immunohistochemistry (IHC) (Technology) World Market Estimates and Forecasts by Region/Country in US$ Million: 2020 to 2027 |
| Immunohistochemistry (IHC) (Technology) Market Share Breakdown by Region/Country: 2020 VS 2027 |
| In Situ Hybridization (ISH) (Technology) World Market by Region/Country in US$ Million: 2020 to 2027 |
| In Situ Hybridization (ISH) (Technology) Market Share Distribution in Percentage by Region/Country: 2020 VS 2027 |
| Next-Generation Sequencing (NGS) (Technology) World Market Estimates and Forecasts in US$ Million by Region/Country: 2020 to 2027 |
| Next-Generation Sequencing (NGS) (Technology) Market Percentage Share Distribution by Region/Country: 2020 VS 2027 |
| Other Technologies (Technology) Market Opportunity Analysis Worldwide in US$ Million by Region/Country: 2020 to 2027 |
| Other Technologies (Technology) Market Share Distribution in Percentage by Region/Country: 2020 VS 2027 |
| Oncology (Indication) World Market by Region/Country in US$ Million: 2020 to 2027 |
| Oncology (Indication) Market Share Breakdown of Worldwide Sales by Region/Country: 2020 VS 2027 |
| Neurology (Indication) Potential Growth Markets Worldwide in US$ Million: 2020 to 2027 |
| Neurology (Indication) Market Sales Breakdown by Region/Country in Percentage: 2020 VS 2027 |
| Other Indications (Indication) Geographic Market Spread Worldwide in US$ Million: 2020 to 2027 |
| Other Indications (Indication) Market Share Distribution in Percentage by Region/Country: 2020 VS 2027 |
| Pharmaceutical & Biopharmaceutical Companies (End-Use) Worldwide Latent Demand Forecasts in US$ Million by Region/Country: 2020-2027 |
| Pharmaceutical & Biopharmaceutical Companies (End-Use) Distribution of Global Sales by Region/Country: 2020 VS 2027 |
| Reference Laboratories (End-Use) Sales Estimates and Forecasts in US$ Million by Region/Country for the Years 2020 through 2027 |
| Reference Laboratories (End-Use) Global Market Share Distribution by Region/Country for 2020 and 2027 |
| CROs (End-Use) Global Opportunity Assessment in US$ Million by Region/Country: 2020-2027 |
| CROs (End-Use) Percentage Share Breakdown of Global Sales by Region/Country: 2020 VS 2027 |
| Other End-Uses (End-Use) Worldwide Sales in US$ Million by Region/Country: 2020-2027 |
| Other End-Uses (End-Use) Market Share Shift across Key Geographies: 2020 VS 2027 |
| III. MARKET ANALYSIS |
| GEOGRAPHIC MARKET ANALYSIS |
| United States |
| Market Facts & Figures |
| US Companion Diagnostics Market Share (in %) by Company: 2018 & 2025 |
| United States Companion Diagnostics Market Estimates and Projections in US$ Million by Product & Service: 2020 to 2027 |
| United States Companion Diagnostics Market Share Breakdown by Product & Service: 2020 VS 2027 |
| Companion Diagnostics Market in US$ Million in the United States by Technology: 2020-2027 |
| United States Companion Diagnostics Market Share Breakdown by Technology: 2020 VS 2027 |
| United States Companion Diagnostics Market Estimates and Projections in US$ Million by Indication: 2020 to 2027 |
| United States Companion Diagnostics Market Share Breakdown by Indication: 2020 VS 2027 |
| United States Companion Diagnostics Latent Demand Forecasts in US$ Million by End-Use: 2020 to 2027 |
| Companion Diagnostics Market Share Breakdown in the United States by End-Use: 2020 VS 2027 |
| Canada |
| Canadian Companion Diagnostics Market Estimates and Forecasts in US$ Million by Product & Service: 2020 to 2027 |
| Companion Diagnostics Market in Canada: Percentage Share Breakdown of Sales by Product & Service for 2020 and 2027 |
| Companion Diagnostics Market Analysis in Canada in US$ Million by Technology: 2020-2027 |
| Canadian Companion Diagnostics Market Share Breakdown by Technology: 2020 VS 2027 |
| Canadian Companion Diagnostics Market Estimates and Forecasts in US$ Million by Indication: 2020 to 2027 |
| Companion Diagnostics Market in Canada: Percentage Share Breakdown of Sales by Indication for 2020 and 2027 |
| Canadian Companion Diagnostics Market Quantitative Demand Analysis in US$ Million by End-Use: 2020 to 2027 |
| Canadian Companion Diagnostics Market Share Analysis by End-Use: 2020 VS 2027 |
| Japan |
| Japanese Market for Companion Diagnostics: Annual Sales Estimates and Projections in US$ Million by Product & Service for the Period 2020-2027 |
| Japanese Companion Diagnostics Market Share Analysis by Product & Service: 2020 VS 2027 |
| Japanese Medium & Long-Term Outlook for Companion Diagnostics Market in US$ Million by Technology: 2020-2027 |
| Japanese Companion Diagnostics Market Percentage Share Distribution by Technology: 2020 VS 2027 |
| Japanese Market for Companion Diagnostics: Annual Sales Estimates and Projections in US$ Million by Indication for the Period 2020-2027 |
| Japanese Companion Diagnostics Market Share Analysis by Indication: 2020 VS 2027 |
| Japanese Demand Estimates and Forecasts for Companion Diagnostics in US$ Million by End-Use: 2020 to 2027 |
| Companion Diagnostics Market Share Shift in Japan by End-Use: 2020 VS 2027 |
| China |
| Chinese Companion Diagnostics Market Growth Prospects in US$ Million by Product & Service for the Period 2020-2027 |
| Chinese Companion Diagnostics Market by Product & Service: Percentage Breakdown of Sales for 2020 and 2027 |
| Companion Diagnostics Market Estimates and Forecasts in China in US$ Million by Technology: 2020-2027 |
| Companion Diagnostics Market in China: Percentage Share Analysis by Technology for 2020 and 2027 |
| Chinese Companion Diagnostics Market Growth Prospects in US$ Million by Indication for the Period 2020-2027 |
| Chinese Companion Diagnostics Market by Indication: Percentage Breakdown of Sales for 2020 and 2027 |
| Chinese Demand for Companion Diagnostics in US$ Million by End-Use: 2020 to 2027 |
| Chinese Companion Diagnostics Market Share Breakdown by End-Use: 2020 VS 2027 |
| Europe |
| Market Facts & Figures |
| European Companion Diagnostics Market: Competitor Market Share Scenario (in %) for 2018 & 2025 |
| European Companion Diagnostics Market Demand Scenario in US$ Million by Region/Country: 2018-2025 |
| European Companion Diagnostics Market Share Shift by Region/Country: 2020 VS 2027 |
| European Companion Diagnostics Market Estimates and Forecasts in US$ Million by Product & Service: 2020-2027 |
| European Companion Diagnostics Market Share Breakdown by Product & Service: 2020 VS 2027 |
| European Companion Diagnostics Market Assessment in US$ Million by Technology: 2020-2027 |
| Companion Diagnostics Market in Europe: Percentage Breakdown of Sales by Technology for 2020 and 2027 |
| European Companion Diagnostics Market Estimates and Forecasts in US$ Million by Indication: 2020-2027 |
| European Companion Diagnostics Market Share Breakdown by Indication: 2020 VS 2027 |
| European Companion Diagnostics Addressable Market Opportunity in US$ Million by End-Use: 2020-2027 |
| European Companion Diagnostics Market Share Analysis by End-Use: 2020 VS 2027 |
| France |
| Companion Diagnostics Market in France by Product & Service: Estimates and Projections in US$ Million for the Period 2020-2027 |
| French Companion Diagnostics Market Share Analysis by Product & Service: 2020 VS 2027 |
| French Companion Diagnostics Market Estimates and Projections in US$ Million by Technology: 2020-2027 |
| French Companion Diagnostics Market Share Breakdown by Technology: 2020 VS 2027 |
| Companion Diagnostics Market in France by Indication: Estimates and Projections in US$ Million for the Period 2020-2027 |
| French Companion Diagnostics Market Share Analysis by Indication: 2020 VS 2027 |
| Companion Diagnostics Quantitative Demand Analysis in France in US$ Million by End-Use: 2020-2027 |
| French Companion Diagnostics Market Share Analysis: A 7-Year Perspective by End-Use for 2020 and 2027 |
| Germany |
| Companion Diagnostics Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Product & Service for the Period 2020-2027 |
| German Companion Diagnostics Market Share Breakdown by Product & Service: 2020 VS 2027 |
| German Companion Diagnostics Latent Demand Forecasts in US$ Million by Technology: 2020-2027 |
| German Companion Diagnostics Market Share Breakdown by Technology: 2020 VS 2027 |
| Companion Diagnostics Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Indication for the Period 2020-2027 |
| German Companion Diagnostics Market Share Breakdown by Indication: 2020 VS 2027 |
| Companion Diagnostics Market in Germany: Annual Sales Estimates and Forecasts in US$ Million by End-Use for the Period 2020-2027 |
| Companion Diagnostics Market Share Distribution in Germany by End-Use: 2020 VS 2027 |
| Italy |
| Italian Companion Diagnostics Market Growth Prospects in US$ Million by Product & Service for the Period 2020-2027 |
| Italian Companion Diagnostics Market by Product & Service: Percentage Breakdown of Sales for 2020 and 2027 |
| Companion Diagnostics Market Estimates and Forecasts in Italy in US$ Million by Technology: 2020-2027 |
| Companion Diagnostics Market in Italy: Percentage Share Analysis by Technology for 2020 and 2027 |
| Italian Companion Diagnostics Market Growth Prospects in US$ Million by Indication for the Period 2020-2027 |
| Italian Companion Diagnostics Market by Indication: Percentage Breakdown of Sales for 2020 and 2027 |
| Italian Demand for Companion Diagnostics in US$ Million by End-Use: 2020 to 2027 |
| Italian Companion Diagnostics Market Share Breakdown by End-Use: 2020 VS 2027 |
| United Kingdom |
| United Kingdom Market for Companion Diagnostics: Annual Sales Estimates and Projections in US$ Million by Product & Service for the Period 2020-2027 |
| United Kingdom Companion Diagnostics Market Share Analysis by Product & Service: 2020 VS 2027 |
| United Kingdom Medium & Long-Term Outlook for Companion Diagnostics Market in US$ Million by Technology: 2020-2027 |
| United Kingdom Companion Diagnostics Market Percentage Share Distribution by Technology: 2020 VS 2027 |
| United Kingdom Market for Companion Diagnostics: Annual Sales Estimates and Projections in US$ Million by Indication for the Period 2020-2027 |
| United Kingdom Companion Diagnostics Market Share Analysis by Indication: 2020 VS 2027 |
| United Kingdom Demand Estimates and Forecasts for Companion Diagnostics in US$ Million by End-Use: 2020 to 2027 |
| Companion Diagnostics Market Share Shift in the United Kingdom by End-Use: 2020 VS 2027 |
| Rest of Europe |
| Rest of Europe Companion Diagnostics Market Estimates and Forecasts in US$ Million by Product & Service: 2020-2027 |
| Rest of Europe Companion Diagnostics Market Share Breakdown by Product & Service: 2020 VS 2027 |
| Rest of Europe Companion Diagnostics Market Assessment in US$ Million by Technology: 2020-2027 |
| Companion Diagnostics Market in Rest of Europe: Percentage Breakdown of Sales by Technology for 2020 and 2027 |
| Rest of Europe Companion Diagnostics Market Estimates and Forecasts in US$ Million by Indication: 2020-2027 |
| Rest of Europe Companion Diagnostics Market Share Breakdown by Indication: 2020 VS 2027 |
| Rest of Europe Companion Diagnostics Addressable Market Opportunity in US$ Million by End-Use: 2020-2027 |
| Rest of Europe Companion Diagnostics Market Share Analysis by End-Use: 2020 VS 2027 |
| Asia-Pacific |
| Companion Diagnostics Market in Asia-Pacific by Product & Service: Estimates and Projections in US$ Million for the Period 2020-2027 |
| Asia-Pacific Companion Diagnostics Market Share Analysis by Product & Service: 2020 VS 2027 |
| Asia-Pacific Companion Diagnostics Market Estimates and Projections in US$ Million by Technology: 2020-2027 |
| Asia-Pacific Companion Diagnostics Historic Market Analysis in US$ Million by Technology: 2020 VS 2027 |
| Companion Diagnostics Market in Asia-Pacific by Indication: Estimates and Projections in US$ Million for the Period 2020-2027 |
| Asia-Pacific Companion Diagnostics Market Share Analysis by Indication: 2020 VS 2027 |
| Companion Diagnostics Quantitative Demand Analysis in Asia-Pacific in US$ Million by End-Use: 2020-2027 |
| Asia-Pacific Companion Diagnostics Market Share Analysis: A 7-Year Perspective by End-Use for 2020 and 2027 |
| Rest of World |
| Rest of World Companion Diagnostics Market Estimates and Forecasts in US$ Million by Product & Service: 2020 to 2027 |
| Companion Diagnostics Market in Rest of World: Percentage Share Breakdown of Sales by Product & Service for 2020 and 2027 |
| Companion Diagnostics Market Analysis in Rest of World in US$ Million by Technology: 2020-2027 |
| Rest of World Companion Diagnostics Market Share Breakdown by Technology: 2020 VS 2027 |
| Rest of World Companion Diagnostics Market Estimates and Forecasts in US$ Million by Indication: 2020 to 2027 |
| Companion Diagnostics Market in Rest of World: Percentage Share Breakdown of Sales by Indication for 2020 and 2027 |
| Rest of World Companion Diagnostics Market Quantitative Demand Analysis in US$ Million by End-Use: 2020 to 2027 |
| Rest of World Companion Diagnostics Market Share Analysis by End-Use: 2020 VS 2027 |
| IV. COMPETITION |
| Total Companies Profiled : 80 Click here to request a full table of contents and more details on this project. |
INSIDER ACCESS TO
METHODOLOGY
QUESTIONNAIRE
INFLUENCER NETWORK
Registration is required to access our data stacks.
RESEARCH PANEL
Panelists are carefully chosen based on their domain expertise and market influence.
Participation in our expert panels is only by invitation. Our project focused panels are constituted of senior executives in business strategy, marketing, sales, and product management at competitive companies worldwide. We also welcome individuals from leading management consulting, venture capital, private equity, investment management and related firms with domain expertise and are actively monitoring specific companies or industries. Our panelists bring unique market perspectives and unbiased intelligence to our ongoing research programs.
Our panelists give 30-minutes a month or a one-time 30-minute participation based on their time and willingness.
- Complimentary previews of full stack research data for participated
- Insider access to research programs including engagements and stats from other panelists
- Unlimited research credits of $1000 per participated project
- Competitive Intelligence Alerts including engagements from other panelists and validated participants worldwide relevant to your company
- Interact with other panelists via our MarketGlassTM Data Exchange Platform*
- BlogX - Panelists can use our blogging platform publish their viewpoints on news relevant to their domain expertise. Platform enables panelists to share their viewpoints on current news and events related to their areas domain expertise with timely and insightful blogs*
* Complete details will be shared with panelists upon formal acceptance.
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com